Cheng Liu
Chief Executive Officer presso ESTRELLA IMMUNOPHARMA, INC.
Patrimonio netto: 368 822 $ in data 31/03/2024
Profilo
Cheng Liu is the founder of Eureka Therapeutics, Inc. (founded in 2006) and holds the title of President, Chief Executive Officer & Director.
Dr. Liu is also the founder of InvisiShield Technologies Ltd., Estrella Biopharma, Inc...
Dr. Liu's current job is Chairman, President & Chief Executive Officer at Estrella Immunopharma, Inc. Dr. Liu is also a Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd.
since 2020.
Dr. Liu's former job was as a Principal Scientist at Chiron Corp.
Dr. Liu was also a Member-Adversary & Executive Committee at SAPA-West from 1998 to 2007.
Dr. Liu's education includes an undergraduate and graduate degree from Peking University and a doctorate degree from the University of California, Berkeley.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
29/09/2023 | 297 437 ( 0.81% ) | 368 822 $ | 31/03/2024 |
Posizioni attive di Cheng Liu
Società | Posizione | Inizio |
---|---|---|
JW (CAYMAN) THERAPEUTICS CO. LTD | Director/Board Member | 30/06/2020 |
ESTRELLA IMMUNOPHARMA, INC. | Chief Executive Officer | - |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Founder | 21/01/2010 |
InvisiShield Technologies Ltd.
InvisiShield Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services InvisiShield Technologies Ltd. is a Caymanian biotechnology company. The company is based in George Town, Cayman Islands. The company was founded by Cheng Liu, Warner C. Greene. Cheng Liu has been the CEO since incorporation. | Chief Executive Officer | - |
Estrella Biopharma, Inc.
Estrella Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Estrella Biopharma, Inc. is a preclinical stage biopharmaceutical company that develops cell therapies for patients with blood cancers and solid tumors. The private company is based in Emeryville, CA. The CEO of the company is Cheng Liu. | Founder | - |
Precedenti posizioni note di Cheng Liu
Società | Posizione | Fine |
---|---|---|
SAPA-West | Corporate Officer/Principal | 01/01/2007 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Formazione di Cheng Liu
Peking University | Graduate Degree |
University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
ESTRELLA IMMUNOPHARMA, INC. | Health Technology |
Aziende private | 5 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Health Technology |
SAPA-West | |
InvisiShield Technologies Ltd.
InvisiShield Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services InvisiShield Technologies Ltd. is a Caymanian biotechnology company. The company is based in George Town, Cayman Islands. The company was founded by Cheng Liu, Warner C. Greene. Cheng Liu has been the CEO since incorporation. | Commercial Services |
Estrella Biopharma, Inc.
Estrella Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Estrella Biopharma, Inc. is a preclinical stage biopharmaceutical company that develops cell therapies for patients with blood cancers and solid tumors. The private company is based in Emeryville, CA. The CEO of the company is Cheng Liu. | Health Technology |
- Borsa valori
- Insiders
- Cheng Liu